ProfileGDS5822 / ILMN_2759828
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 32% 3% 42% 33% 7% 26% 24% 14% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 115.932
GSM1276600PDAC Late Ablation Control 28.63
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 116.642
GSM1276603PDAC Late Ablation 216.233
GSM1276604PDAC Late Ablation 36.77
GSM1303940PDAC Late Ablation_anti-CTLA4 114.526
GSM1303941PDAC Late Ablation_anti-CTLA4 212.224
GSM1303942PDAC Late Ablation_anti-CTLA4 38.314